Abiopharma

News list

Lee Han Myung 🟢 acquired 88.0K shares (1 derivative) of Century Therapeutics, Inc. (IPSC) at $0.59 Transaction Date: Dec 09, 2025 | Filing ID: 000004

Full text

News bot Dec. 11, 2025, 11:06 p.m.
🔍 Lee Han Myung (Executive)

Company: Century Therapeutics, Inc. (IPSC)

Report Date: 2025-12-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 88,000
Detailed Transactions and Holdings:
- Acquired 88,000 shares of Stock Option (right to buy) at $0.592 per share (Derivative)
  Date: 2025-12-09 | Code: A | Expires: 2035-12-09 | equity_swap_involved: 0 | shares_owned_after: 88,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.